Skip to search formSkip to main contentSkip to account menu

VS-105

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Vitamin D receptor agonist VS-105 directly modulates parathyroid hormone expression in human parathyroid cells and in 5/6 nephrectomized rats
2016
2016
Cardiac effect of vitamin D receptor modulators in uremic rats
2015
2015
Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5/6 nephrectomized rats.
Vitamin D receptor (VDR) agonists (VDRAs) are commonly used to manage hyperparathyroidism secondary to chronic kidney disease… 
2013
2013
Synthesis of VS-105: A novel and potent vitamin D receptor agonist with reduced hypercalcemic effects.
2011
2011
VS‐105: a novel vitamin D receptor modulator with cardiovascular protective effects
BACKGROUND AND PURPOSE Vitamin D receptor (VDR) modulators (VDRMs) such as calcitriol, paricalcitol and doxercalciferol are… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)